BioSpace News Archive

Business

Eli Lilly Taps Anne White to Take Over Oncology Division

Eli Lilly Oncology will have a new president at the helm of the division. Industry veteran Anne White has been tapped to lead the division beginning Sept. 1. She replaced Sue Mahoney whose last day with the company is today.

August 31, 2018
·
2 min read
·
Alex Keown
Drug Development

AstraZeneca’s Lupus Drug Flunks Phase III Clinical Trial

AstraZeneca and MedImmune announced top-line results from its TULIP 1 Phase III clinical trial of anifrolumab in adults with moderate-to-severe systemic lupus erythematosus (SLE). Unfortunately, the drug didn’t meet the trials primary endpoint of statistically-significant reduction in disease activity.

August 31, 2018
·
2 min read
·
Mark Terry
FDA

FDA Approves Eight Novel Drugs in August

The U.S. Food and Drug Administration has had a busy August. In addition to the number of draft guidance documents the agency issued during the month, the FDA has also been busy approving a number of new treatments for a variety of diseases.

August 31, 2018
·
3 min read
·
Alex Keown
Drug Development

Researchers Use CRISPR to Treat Duchenne Muscular Dystrophy in Dogs

Researchers at the University of Texas Southwestern Medical Center used CRISPR gene editing to treat Duchenne muscular dystrophy (DMD) in dogs. Their work was published in the journal Science.

August 31, 2018
·
3 min read
·
Mark Terry
Business

EMD Serono Taps Rehan Verjee as New President

EMD Serono is shaking up its leadership. The biopharmaceutical arm of Germany-based Merck KGaA named Rehan Verjee as the new president of EMD Serono and global head of innovative medicine franchises at the parent company.

August 31, 2018
·
2 min read
·
Alex Keown